Robert Littlefield

Robert is a Director for the Prescient Intelligence & Insight business. He earned his MSc in biomedical engineering from Columbia University and his BASc in biomedical engineering from Bucknell University. He has over 10 years of experience in biopharmaceutical commercial strategy, market insights, data and analytics, business reporting and competitive intelligence. His market analysis has been featured in The New York Times, The Wall Street Journal, Forbes and Thomson Reuters. Before joining Prescient, Robert led diverse projects in strategy and intelligence for several biopharmaceutical companies including Juniper Pharma and Intarcia Therapeutics in various therapeutic areas, including oncology, women’s health, rare diseases and diabetes. At Prescient, Rob is responsible for driving the Intelligence & Insight team’s growth by ensuring engagements are of high quality, expanding Prescient’s presence in the greater Boston area and supporting team professional development.